Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
03/29/2012 | WO2011063990A3 Spider silk particles for controlled and sustained delivery of compounds |
03/29/2012 | WO2011010084A8 Cyclosporin conjugates |
03/29/2012 | WO2010149196A8 Taste masked dosage form of pharmaceutically acceptable salt of escitalopram |
03/29/2012 | US20120077888 Orodispersible tablets |
03/29/2012 | US20120077887 Terpolymers as pressure-sensitive adhesives |
03/29/2012 | US20120077886 Hydrophilic polyproylene melt additives |
03/29/2012 | US20120077822 In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers |
03/29/2012 | US20120077764 Compositions and method for treating infection in cattle and swine |
03/29/2012 | US20120077740 Methods for making Apo-2 Ligand using divalent metal ions |
03/29/2012 | US20120076856 Orodispersible pharmaceutical composition of perindopril |
03/29/2012 | US20120076852 Drug carrier and drug carrier kit for inhibiting fibrosis |
03/29/2012 | US20120076773 Novel Drug Delivery Devices |
03/29/2012 | US20120076771 Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials |
03/29/2012 | US20120076749 Modified Blood Factors Comprising a Low Degree of Water Soluble Polymer |
03/29/2012 | US20120076742 Topical drug delivery system with dual carriers |
03/29/2012 | US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans |
03/29/2012 | US20120076723 Devices and methods for the treatment of cancer |
03/29/2012 | US20120074614 Systems, methods and apparatuses for manufacturing dosage forms |
03/29/2012 | CA2849382A1 Therapeutic applications of smad7 |
03/29/2012 | CA2812416A1 Human b1 cells and uses thereof |
03/29/2012 | CA2811962A1 Enhanced transbuccal drug delivery system and compositions |
03/29/2012 | CA2811919A1 Oral composition and method of forming and using same |
03/29/2012 | CA2811869A1 Tunable, biodegradable linker molecules for transient conjugation of components in drug delivery systems, and drug delivery systems prepared therewith |
03/29/2012 | CA2811692A1 Novel block copolymer and micelle compositions and methods of use thereof |
03/29/2012 | CA2811601A1 Aptamer conjugates for targeting of therapeutic and/or diagnostic nanocarriers |
03/29/2012 | CA2810112A1 Caspofungin composition |
03/29/2012 | CA2809858A1 Novel low molecular weight cationic lipids for oligonucleotide delivery |
03/29/2012 | CA2809646A1 5.alpha.-androstane-3.beta.,5,6.beta.-triol injection and preparation method therefor |
03/29/2012 | CA2780785A1 Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same |
03/29/2012 | CA2780771A1 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing sames |
03/28/2012 | EP2433655A2 Homoarginine-prodrugs of amphetamine |
03/28/2012 | EP2433654A2 Citrulline and homocitrulline prodrugs of amphetamines and processes for making and using the same |
03/28/2012 | EP2433653A1 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
03/28/2012 | EP2433651A1 Method for detecting aldehydes and ketones in glycerine |
03/28/2012 | EP2433630A1 Self-emulsifying composition of 3 fatty acid |
03/28/2012 | EP2433618A1 Easy-disintegrating polymeric micelle composition |
03/28/2012 | EP2433502A1 Bitterness-suppressing agent |
03/28/2012 | EP2432498A1 A method for keeping an immunogenic composition available for administration to an animal |
03/28/2012 | EP2432495A2 Elastin for soft tissue augmentation |
03/28/2012 | EP2432492A2 Application and uses of prg4 and therapeutic modulation thereof |
03/28/2012 | EP2432489A2 Variants of c-type natriuretic peptide |
03/28/2012 | EP2432451A2 Compositions for the treatment of metastatic cancer and methods of use thereof |
03/28/2012 | EP2112999B1 Non-natural recombinant gelatins with enhanced functionality |
03/28/2012 | EP1919945B1 Mutant of granulocyte-colony stimulating factor(g-csf) and chemically conjugated polypeptide thereof |
03/28/2012 | EP1859041B1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
03/28/2012 | EP1765894B1 Novel temperature and ph sensitive copolymers |
03/28/2012 | EP1569676B1 Calcitonin drug-oligomer conjugates, and uses thereof |
03/28/2012 | EP1543830B1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
03/28/2012 | EP1453508B1 Tempamine compositions and use against cellular oxidative damage |
03/28/2012 | EP0877562B2 Water dispersible compositions containing natural hydrophilic, water-insoluble pigments, methods of preparing same and their use |
03/28/2012 | CN1893892B Pharmaceutical formulations of camptothecins and process for making same |
03/28/2012 | CN1635901B Remodeling and glycoconjugation of peptides |
03/28/2012 | CN102395598A Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions |
03/28/2012 | CN102395401A Drug delivery through hydrogel plugs |
03/28/2012 | CN102395380A Pretargeting kit, method and agents used therein |
03/28/2012 | CN102395379A New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor |
03/28/2012 | CN102395378A Bi-functional co-polymer use for ophthalmic and other topical and local applications |
03/28/2012 | CN102395370A Methods for inhibiting angiogenesis with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
03/28/2012 | CN102395361A Bioavailable capsule compositions of amorphous alpha-(n-sulfonamido)acetamide compound |
03/28/2012 | CN102395355A Particle size-structured parenteral dispersions |
03/28/2012 | CN102395354A Microneedle array using porous substrate and process for producing same |
03/28/2012 | CN102391537A Multilayer aquagel, and preparation method and application thereof |
03/28/2012 | CN102391517A Nanometer micelle capable of intelligently releasing medicine as well as preparation method and application thereof |
03/28/2012 | CN102391504A Copolymer, glucose sensitive micelle, glucose sensitive medicine-carrying micelle and preparation method thereof |
03/28/2012 | CN102391499A Preparation method of polymer for quickly releasing active components of masticinic acid under exciting of reduction |
03/28/2012 | CN102391498A Polyethylene glycol di-fatty acid glyceride derivatives and application thereof to medicine delivery |
03/28/2012 | CN102391493A Polyalkylene glycol containing reduced amount of oligomer |
03/28/2012 | CN102391446A Method for preparing biocompatible polymer nano-vesicle in pure water |
03/28/2012 | CN102391429A PH-sensitive xylan hydrogel and preparation method thereof |
03/28/2012 | CN102391377A Fusion protein capable of inducing and activating cancer targeting T-cells as well as preparation method and application of the fusion protein |
03/28/2012 | CN102389573A Medicament for treating malignant glioma and preparation method thereof |
03/28/2012 | CN102389572A Chitosan-carboxylated chitosan nanosphere loading insoluble antitumor drug and preparation method and application thereof |
03/28/2012 | CN102389571A Medicine sustained-release suppository used for in-vivo injection |
03/28/2012 | CN102389570A Antiseptic-free vaccine |
03/28/2012 | CN102389563A Transdermal absorption traditional Chinese medicinal blood pressure protection bag and its preparation method |
03/28/2012 | CN102389511A Anti-radiation Chinese medicine preparation and preparation method thereof |
03/28/2012 | CN102389422A Intranasal compositions |
03/28/2012 | CN102389405A Tripterine oral self-emulsification dispersible tablet and its preparation method |
03/28/2012 | CN102389403A Freeze dried monophosphate adenine arabinoside powder injection for injection and preparation method thereof |
03/28/2012 | CN102389401A Dexibuprofen particles and preparation method thereof |
03/28/2012 | CN102389399A Preparation method of drug-loaded microspheres capable of enhancing anticancer effect of paclitaxel by ultraviolet radiation and application thereof |
03/28/2012 | CN102389398A Chitosan-loaded capsaicin microspheres, preparation method thereof, and application thereof |
03/28/2012 | CN102389397A Preparation method of ibuprofen enteric particles |
03/28/2012 | CN102389396A Pioglitazone hydrochloride solid dispersoid and medicinal compound thereof as well as preparation methods and applications thereof |
03/28/2012 | CN102389395A Preparation of n-HA/PLGA electrostatic spinning composite nanofiber medicament loading system |
03/28/2012 | CN102389393A Pefloxacin mesylate emulsion and preparation method thereof |
03/28/2012 | CN102389392A Recombinant bovine basic fibroblast growth factor gel for eye use |
03/28/2012 | CN102145001B Stable aztreonam composition and preparation method thereof |
03/28/2012 | CN102113997B Domperidone suspension and preparation method thereof |
03/28/2012 | CN102070756B Sugar-responsive medicament delivery material and preparation method thereof |
03/28/2012 | CN102018736B Natural indigo decoction piece and preparation method thereof |
03/28/2012 | CN101856332B Method for preparing 8, 9-single-epoxy brevifolin PLGA microspheres |
03/28/2012 | CN101849927B Hot-melt pressure-sensitive adhesive transdermal patch containing alpha-asarone and preparation method thereof |
03/28/2012 | CN101843595B Formula of oral mucosa absorbing dosage form of medicines of polypeptides and proteins, and preparation method and application thereof |
03/28/2012 | CN101785864B Post-crosslinking hydrophilic patch substrate and preparation method thereof |
03/28/2012 | CN101757078B Compound poultice for treating mumps and preparation method thereof |
03/28/2012 | CN101732240B Externally used ointment for relieving pain and activating blood circulation |
03/28/2012 | CN101698095B Drug composition liniment or lotion for treating white vein diseases and preparation method thereof |
03/28/2012 | CN101690823B Method for preparing RGDV-containing cytosine arabinoside conjugate pharmacosome and application as antitumor agent |
03/28/2012 | CN101683524B Method for preparing bacterial ghost by combination of antibacterial peptide and ultrahigh pressure and application thereof |